Literature DB >> 3756081

A novel technique for measuring human tissue pO2 at the cellular level.

R C Urtasun, C J Koch, A J Franko, J A Raleigh, J D Chapman.   

Abstract

Some electron-affinic drugs, developed as hypoxic cell radiosensitizers, become selectively bound to the molecules of hypoxic cells by metabolism. This technique has been used to identify zones of chronically hypoxic cells in multicellular spheroids and animal tumours. Tritiated-misonidazole was administered to a patient with advanced melanoma 22 h prior to the surgical resection of a large metastatic s.c. lesion growing on the face. Autoradiographic analysis of histological sections revealed zones of intense labelling by the radioactive drug, indicative of tumour cells which were chronically hypoxic. This technique appears to provide an indirect measurement of tissue pO2 at the cellular level from which estimates of the tumour hypoxic fraction can be made. These data are encouraging as regards the development of 'sensitizer-adduct' procedures for the invasive and non-invasive measurement of hypoxia in both tumours and normal tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756081      PMCID: PMC2001637          DOI: 10.1038/bjc.1986.197

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Quantitative measurements of oxygen tension in normal tissues and in the tumours of patients before and after radiotherapy.

Authors:  D B CATER; I A SILVER
Journal:  Acta radiol       Date:  1960-03       Impact factor: 1.990

2.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

3.  A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors.

Authors:  I F Tannock
Journal:  Cancer Res       Date:  1969-08       Impact factor: 12.701

4.  Binding of misonidazole to EMt6 and V79 spheroids.

Authors:  A J Franko; J D Chapman; C J Koch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982 Mar-Apr       Impact factor: 7.038

5.  Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation.

Authors:  T W Wong; G F Whitmore; S Gulyas
Journal:  Radiat Res       Date:  1978-09       Impact factor: 2.841

6.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data.

Authors:  J E Moulder; S Rockwell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-05       Impact factor: 7.038

7.  The detection and measurement of hypoxic cells in solid tumors.

Authors:  J D Chapman
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

8.  Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.

Authors:  J A Raleigh; A J Franko; C J Koch; J L Born
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

9.  A marker for hypoxic cells in tumours with potential clinical applicability.

Authors:  J D Chapman; A J Franko; J Sharplin
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

10.  Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.

Authors:  A J Franko; J D Chapman
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

View more
  17 in total

1.  Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.

Authors:  J D Chapman; L R Coia; C C Stobbe; E L Engelhardt; M C Fenning; R F Schneider
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 2.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

Review 3.  Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).

Authors:  W A Denny; W R Wilson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

4.  AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization.

Authors:  Anja Bastian; Satoshi Matsuzaki; Kenneth M Humphries; Gavin A Pharaoh; Arpit Doshi; Nilesh Zaware; Aleem Gangjee; Michael A Ihnat
Journal:  Cancer Lett       Date:  2016-12-08       Impact factor: 8.679

5.  Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.

Authors:  J M Cline; D E Thrall; R L Page; A J Franko; J A Raleigh
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 6.  The impact of O2 availability on human cancer.

Authors:  Jessica A Bertout; Shetal A Patel; M Celeste Simon
Journal:  Nat Rev Cancer       Date:  2008-11-06       Impact factor: 60.716

7.  Reducing the hypoxic fraction of a tumour model by growth in low glucose.

Authors:  L Hlatky; R K Sachs; C S Ring
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

8.  Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells.

Authors:  M B Parliament; L I Wiebe; A J Franko
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

9.  Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study.

Authors:  M B Parliament; J D Chapman; R C Urtasun; A J McEwan; L Golberg; J R Mercer; R H Mannan; L I Wiebe
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

10.  Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.

Authors:  J A Raleigh; G G Miller; A J Franko; C J Koch; A F Fuciarelli; D A Kelly
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.